APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ketorolac Tromethamine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ketorolac Tromethamine Industry Growth and Trends Forecast to 2032

22 December 2025116 pages

Choose your research edition.

Industry ResearchKetorolac Tromethamine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Ketorolac Tromethamine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Ketorolac Tromethamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ketorolac Tromethamine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Ketorolac Tromethamine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Ketorolac Tromethamine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ketorolac Tromethamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ketorolac Tromethamine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Pfizer, Sagent Pharmaceuticals, Omeros Corporation, Gland Pharma Limited and Egalet US Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ketorolac Tromethamine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ketorolac Tromethamine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ketorolac Tromethamine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ketorolac Tromethamine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ketorolac Tromethamine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ketorolac Tromethamine Market by Company

Teva

Sun Pharmaceutical

Sandoz

Mylan

Pfizer

Sagent Pharmaceuticals

Omeros Corporation

Gland Pharma Limited

Egalet US Inc.

Dr. Reddy’s Laboratories

Aurobindo Pharma

Apotex

Amphastar Pharmaceuticals

Allergan

Akorn

Ketorolac Tromethamine Segment by Type

Nasal

Oral tablet

Ophthalmic

Injection

Ketorolac Tromethamine Segment by Application

Hospital

Clinic

Others

Ketorolac Tromethamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Tromethamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ketorolac Tromethamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Tromethamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ketorolac Tromethamine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ketorolac Tromethamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Table 2. Major Company of Oral tablet Table 3. Major Company of Ophthalmic Table 4. Major Company of Injection Table 5. Global Ketorolac Tromethamine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 7. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2021-2026) Table 8. Global Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 9. Global Ketorolac Tromethamine Sales Market Share in Value by Type (2021-2026) Table 10. Global Ketorolac Tromethamine Price by Type (2021-2026) & (US$/unit) Table 11. Global Ketorolac Tromethamine Sales by Type (2027-2032) & (k units) Table 12. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2027-2032) Table 13. Global Ketorolac Tromethamine Sales by Type (2027-2032) & (US$ Million) Table 14. Global Ketorolac Tromethamine Sales Market Share in Value by Type (2027-2032) Table 15. Global Ketorolac Tromethamine Price by Type (2027-2032) & (US$/unit) Table 16. North America Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 17. North America Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 19. Europe Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 23. Latin America Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Ketorolac Tromethamine Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Ketorolac Tromethamine Sales by Type (2021-2026) & (US$ Million) Table 26. Ketorolac Tromethamine Industry Trends Table 27. Ketorolac Tromethamine Industry Drivers Table 28. Ketorolac Tromethamine Industry Opportunities and Challenges Table 29. Ketorolac Tromethamine Industry Restraints Table 30. Global Ketorolac Tromethamine Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Ketorolac Tromethamine Revenue Market Share by Company (2021-2026) Table 32. Global Ketorolac Tromethamine Sales by Company (2021-2026) & (k units) Table 33. Global Ketorolac Tromethamine Sales Share by Company (2021-2026) Table 34. Global Ketorolac Tromethamine Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Ketorolac Tromethamine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Ketorolac Tromethamine Major Company Production Sites and Headquarters Table 37. Global Ketorolac Tromethamine Company, Product Type & Application Table 38. Global Ketorolac Tromethamine Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Ketorolac Tromethamine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Ketorolac Tromethamine Sales by Region (2021-2026) & (k units) Table 43. Global Ketorolac Tromethamine Sales Market Share in Volume by Region (2021-2026) Table 44. Global Ketorolac Tromethamine Sales by Region (2021-2026) & (US$ Million) Table 45. Global Ketorolac Tromethamine Sales Market Share in Value by Region (2021-2026) Table 46. Global Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Ketorolac Tromethamine Sales by Region (2027-2032) & (k units) Table 48. Global Ketorolac Tromethamine Sales Market Share in Volume by Region (2027-2032) Table 49. Global Ketorolac Tromethamine Sales by Region (2027-2032) & (US$ Million) Table 50. Global Ketorolac Tromethamine Sales Market Share in Value by Region (2027-2032) Table 51. Global Ketorolac Tromethamine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Ketorolac Tromethamine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 54. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2021-2026) Table 55. Global Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 56. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2021-2026) Table 57. Global Ketorolac Tromethamine Price by Application (2021-2026) & (US$/unit) Table 58. Global Ketorolac Tromethamine Sales by Application (2027-2032) & (k units) Table 59. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2027-2032) Table 60. Global Ketorolac Tromethamine Sales by Application (2027-2032) & (US$ Million) Table 61. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2027-2032) Table 62. Global Ketorolac Tromethamine Price by Application (2027-2032) & (US$/unit) Table 63. North America Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 64. North America Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 66. Europe Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 70. Latin America Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Ketorolac Tromethamine Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Ketorolac Tromethamine Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Teva Ketorolac Tromethamine Product Portfolio Table 77. Teva Recent Development Table 78. Sun Pharmaceutical Company Information Table 79. Sun Pharmaceutical Business Overview Table 80. Sun Pharmaceutical Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio Table 82. Sun Pharmaceutical Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Sandoz Ketorolac Tromethamine Product Portfolio Table 87. Sandoz Recent Development Table 88. Mylan Company Information Table 89. Mylan Business Overview Table 90. Mylan Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Mylan Ketorolac Tromethamine Product Portfolio Table 92. Mylan Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Pfizer Ketorolac Tromethamine Product Portfolio Table 97. Pfizer Recent Development Table 98. Sagent Pharmaceuticals Company Information Table 99. Sagent Pharmaceuticals Business Overview Table 100. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 102. Sagent Pharmaceuticals Recent Development Table 103. Omeros Corporation Company Information Table 104. Omeros Corporation Business Overview Table 105. Omeros Corporation Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Omeros Corporation Ketorolac Tromethamine Product Portfolio Table 107. Omeros Corporation Recent Development Table 108. Gland Pharma Limited Company Information Table 109. Gland Pharma Limited Business Overview Table 110. Gland Pharma Limited Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Gland Pharma Limited Ketorolac Tromethamine Product Portfolio Table 112. Gland Pharma Limited Recent Development Table 113. Egalet US Inc. Company Information Table 114. Egalet US Inc. Business Overview Table 115. Egalet US Inc. Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Egalet US Inc. Ketorolac Tromethamine Product Portfolio Table 117. Egalet US Inc. Recent Development Table 118. Dr. Reddy’s Laboratories Company Information Table 119. Dr. Reddy’s Laboratories Business Overview Table 120. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio Table 122. Dr. Reddy’s Laboratories Recent Development Table 123. Aurobindo Pharma Company Information Table 124. Aurobindo Pharma Business Overview Table 125. Aurobindo Pharma Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Aurobindo Pharma Ketorolac Tromethamine Product Portfolio Table 127. Aurobindo Pharma Recent Development Table 128. Apotex Company Information Table 129. Apotex Business Overview Table 130. Apotex Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Apotex Ketorolac Tromethamine Product Portfolio Table 132. Apotex Recent Development Table 133. Amphastar Pharmaceuticals Company Information Table 134. Amphastar Pharmaceuticals Business Overview Table 135. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio Table 137. Amphastar Pharmaceuticals Recent Development Table 138. Allergan Company Information Table 139. Allergan Business Overview Table 140. Allergan Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Allergan Ketorolac Tromethamine Product Portfolio Table 142. Allergan Recent Development Table 143. Akorn Company Information Table 144. Akorn Business Overview Table 145. Akorn Ketorolac Tromethamine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Akorn Ketorolac Tromethamine Product Portfolio Table 147. Akorn Recent Development Table 148. North America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. North America Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 150. North America Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 151. North America Ketorolac Tromethamine Sales Forecast by Country (2027-2032) & (k units) Table 152. North America Ketorolac Tromethamine Sales Market Share Forecast by Country (2027-2032) Table 153. North America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Ketorolac Tromethamine Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Ketorolac Tromethamine Market Share by Country (2021-2026) Table 156. North America Ketorolac Tromethamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Ketorolac Tromethamine Market Share Forecast by Country (2027-2032) Table 158. Europe Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Europe Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 160. Europe Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 161. Europe Ketorolac Tromethamine Sales Forecast by Country (2027-2032) & (k units) Table 162. Europe Ketorolac Tromethamine Sales Market Share Forecast by Country (2027-2032) Table 163. Europe Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Europe Ketorolac Tromethamine Market Size by Country (2021-2026) & (US$ Million) Table 165. Europe Ketorolac Tromethamine Market Share by Country (2021-2026) Table 166. Europe Ketorolac Tromethamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Europe Ketorolac Tromethamine Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 170. Asia-Pacific Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 171. Asia-Pacific Ketorolac Tromethamine Sales Forecast by Country (2027-2032) & (k units) Table 172. Asia-Pacific Ketorolac Tromethamine Sales Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Ketorolac Tromethamine Market Size by Country (2021-2026) & (US$ Million) Table 175. Asia-Pacific Ketorolac Tromethamine Market Share by Country (2021-2026) Table 176. Asia-Pacific Ketorolac Tromethamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Asia-Pacific Ketorolac Tromethamine Market Share Forecast by Country (2027-2032) Table 178. Latin America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 179. Latin America Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 180. Latin America Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 181. Latin America Ketorolac Tromethamine Sales Forecast by Country (2027-2032) & (k units) Table 182. Latin America Ketorolac Tromethamine Sales Market Share Forecast by Country (2027-2032) Table 183. Latin America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Ketorolac Tromethamine Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Ketorolac Tromethamine Market Share by Country (2021-2026) Table 186. Latin America Ketorolac Tromethamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Ketorolac Tromethamine Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Ketorolac Tromethamine Sales by Country (2021-2026) & (k units) Table 190. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2021-2026) Table 191. Middle East and Africa Ketorolac Tromethamine Sales Forecast by Country (2027-2032) & (k units) Table 192. Middle East and Africa Ketorolac Tromethamine Sales Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Ketorolac Tromethamine Market Size by Country (2021-2026) & (US$ Million) Table 195. Middle East and Africa Ketorolac Tromethamine Market Share by Country (2021-2026) Table 196. Middle East and Africa Ketorolac Tromethamine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Middle East and Africa Ketorolac Tromethamine Market Share Forecast by Country (2027-2032) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Ketorolac Tromethamine Distributors List Table 201. Ketorolac Tromethamine Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Ketorolac Tromethamine Image Figure 2. Global Ketorolac Tromethamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ketorolac Tromethamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Ketorolac Tromethamine Sales (2021-2032) & (k units) Figure 5. Nasal Image Figure 6. Global Nasal Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral tablet Image Figure 8. Global Oral tablet Sales YoY Growth (2021-2032) & (k units) Figure 9. Ophthalmic Image Figure 10. Global Ophthalmic Sales YoY Growth (2021-2032) & (k units) Figure 11. Injection Image Figure 12. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Ketorolac Tromethamine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Ketorolac Tromethamine Market Share by Type 2025 VS 2032 Figure 15. North America Ketorolac Tromethamine Sales Market Share in Volume by Type in 2025 Figure 16. North America Ketorolac Tromethamine Sales Market Share in Value by Type in 2025 Figure 17. Europe Ketorolac Tromethamine Sales Market Share in Volume by Type in 2025 Figure 18. Europe Ketorolac Tromethamine Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Type in 2025 Figure 21. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Ketorolac Tromethamine Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Ketorolac Tromethamine Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Ketorolac Tromethamine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Ketorolac Tromethamine Market Share by Application 2025 VS 2032 Figure 35. North America Ketorolac Tromethamine Sales Market Share in Volume by Application in 2025 Figure 36. North America Ketorolac Tromethamine Sales Market Share in Value by Application in 2025 Figure 37. Europe Ketorolac Tromethamine Sales Market Share in Volume by Application in 2025 Figure 38. Europe Ketorolac Tromethamine Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Ketorolac Tromethamine Sales Market Share in Value by Application in 2025 Figure 41. Latin America Ketorolac Tromethamine Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Ketorolac Tromethamine Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Ketorolac Tromethamine Sales Market Share in Value by Application in 2025 Figure 45. North America Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Ketorolac Tromethamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Ketorolac Tromethamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Ketorolac Tromethamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Ketorolac Tromethamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Ketorolac Tromethamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Ketorolac Tromethamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Ketorolac Tromethamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Ketorolac Tromethamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Ketorolac Tromethamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Ketorolac Tromethamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Ketorolac Tromethamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Ketorolac Tromethamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Ketorolac Tromethamine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Ketorolac Tromethamine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Ketorolac Tromethamine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Ketorolac Tromethamine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Ketorolac Tromethamine Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Ketorolac Tromethamine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal
  • Oral tablet
  • Ophthalmic
  • Injection
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Pfizer
  • Sagent Pharmaceuticals
  • Omeros Corporation
  • Gland Pharma Limited
  • Egalet US Inc.
  • Dr. Reddy’s Laboratories
  • Aurobindo Pharma
  • Apotex
  • Amphastar Pharmaceuticals
  • Allergan
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ketorolac Tromethamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ketorolac Tromethamine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ketorolac Tromethamine Market by Type
  6. 1.3.1 Nasal
  7. 1.3.2 Oral tablet
  8. 1.3.3 Ophthalmic
  9. 1.3.4 Injection
  10. 1.4 Global Ketorolac Tromethamine Market Size by Type
  11. 1.4.1 Global Ketorolac Tromethamine Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Ketorolac Tromethamine Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Ketorolac Tromethamine Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Ketorolac Tromethamine Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Ketorolac Tromethamine Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Ketorolac Tromethamine Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Ketorolac Tromethamine Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Ketorolac Tromethamine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ketorolac Tromethamine Industry Trends
  2. 2.2 Ketorolac Tromethamine Industry Drivers
  3. 2.3 Ketorolac Tromethamine Industry Opportunities and Challenges
  4. 2.4 Ketorolac Tromethamine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ketorolac Tromethamine Revenue (2021-2026)
  2. 3.2 Global Top Players by Ketorolac Tromethamine Sales (2021-2026)
  3. 3.3 Global Top Players by Ketorolac Tromethamine Price (2021-2026)
  4. 3.4 Global Ketorolac Tromethamine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ketorolac Tromethamine Major Company Production Sites & Headquarters
  6. 3.6 Global Ketorolac Tromethamine Company, Product Type & Application
  7. 3.7 Global Ketorolac Tromethamine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ketorolac Tromethamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ketorolac Tromethamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ketorolac Tromethamine Tier 1, Tier 2, and Tier 3
4 Ketorolac Tromethamine Regional Status and Outlook
  1. 4.1 Global Ketorolac Tromethamine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ketorolac Tromethamine Historic Market Size by Region
  3. 4.2.1 Global Ketorolac Tromethamine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ketorolac Tromethamine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ketorolac Tromethamine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ketorolac Tromethamine Forecasted Market Size by Region
  7. 4.3.1 Global Ketorolac Tromethamine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ketorolac Tromethamine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ketorolac Tromethamine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ketorolac Tromethamine by Application
  1. 5.1 Ketorolac Tromethamine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Ketorolac Tromethamine Market Size by Application
  6. 5.2.1 Global Ketorolac Tromethamine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Ketorolac Tromethamine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Ketorolac Tromethamine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Ketorolac Tromethamine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Ketorolac Tromethamine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Ketorolac Tromethamine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Ketorolac Tromethamine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Ketorolac Tromethamine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Ketorolac Tromethamine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Ketorolac Tromethamine Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Ketorolac Tromethamine Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Ketorolac Tromethamine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Sagent Pharmaceuticals
  32. 6.6.1 Sagent Pharmaceuticals Company Information
  33. 6.6.2 Sagent Pharmaceuticals Business Overview
  34. 6.6.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  36. 6.6.5 Sagent Pharmaceuticals Recent Developments
  37. 6.7 Omeros Corporation
  38. 6.7.1 Omeros Corporation Company Information
  39. 6.7.2 Omeros Corporation Business Overview
  40. 6.7.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio
  42. 6.7.5 Omeros Corporation Recent Developments
  43. 6.8 Gland Pharma Limited
  44. 6.8.1 Gland Pharma Limited Company Information
  45. 6.8.2 Gland Pharma Limited Business Overview
  46. 6.8.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio
  48. 6.8.5 Gland Pharma Limited Recent Developments
  49. 6.9 Egalet US Inc.
  50. 6.9.1 Egalet US Inc. Company Information
  51. 6.9.2 Egalet US Inc. Business Overview
  52. 6.9.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio
  54. 6.9.5 Egalet US Inc. Recent Developments
  55. 6.10 Dr. Reddy’s Laboratories
  56. 6.10.1 Dr. Reddy’s Laboratories Company Information
  57. 6.10.2 Dr. Reddy’s Laboratories Business Overview
  58. 6.10.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio
  60. 6.10.5 Dr. Reddy’s Laboratories Recent Developments
  61. 6.11 Aurobindo Pharma
  62. 6.11.1 Aurobindo Pharma Company Information
  63. 6.11.2 Aurobindo Pharma Business Overview
  64. 6.11.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio
  66. 6.11.5 Aurobindo Pharma Recent Developments
  67. 6.12 Apotex
  68. 6.12.1 Apotex Company Information
  69. 6.12.2 Apotex Business Overview
  70. 6.12.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Apotex Ketorolac Tromethamine Product Portfolio
  72. 6.12.5 Apotex Recent Developments
  73. 6.13 Amphastar Pharmaceuticals
  74. 6.13.1 Amphastar Pharmaceuticals Company Information
  75. 6.13.2 Amphastar Pharmaceuticals Business Overview
  76. 6.13.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio
  78. 6.13.5 Amphastar Pharmaceuticals Recent Developments
  79. 6.14 Allergan
  80. 6.14.1 Allergan Company Information
  81. 6.14.2 Allergan Business Overview
  82. 6.14.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Allergan Ketorolac Tromethamine Product Portfolio
  84. 6.14.5 Allergan Recent Developments
  85. 6.15 Akorn
  86. 6.15.1 Akorn Company Information
  87. 6.15.2 Akorn Business Overview
  88. 6.15.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Akorn Ketorolac Tromethamine Product Portfolio
  90. 6.15.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America Ketorolac Tromethamine Sales by Country
  2. 7.1.1 North America Ketorolac Tromethamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ketorolac Tromethamine Sales by Country (2021-2026)
  4. 7.1.3 North America Ketorolac Tromethamine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ketorolac Tromethamine Market Size by Country
  6. 7.2.1 North America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ketorolac Tromethamine Market Size by Country (2021-2026)
  8. 7.2.3 North America Ketorolac Tromethamine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ketorolac Tromethamine Sales by Country
  2. 8.1.1 Europe Ketorolac Tromethamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ketorolac Tromethamine Sales by Country (2021-2026)
  4. 8.1.3 Europe Ketorolac Tromethamine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ketorolac Tromethamine Market Size by Country
  6. 8.2.1 Europe Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ketorolac Tromethamine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ketorolac Tromethamine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ketorolac Tromethamine Sales by Country
  2. 9.1.1 Asia-Pacific Ketorolac Tromethamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ketorolac Tromethamine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ketorolac Tromethamine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ketorolac Tromethamine Market Size by Country
  6. 9.2.1 Asia-Pacific Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ketorolac Tromethamine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ketorolac Tromethamine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ketorolac Tromethamine Sales by Country
  2. 10.1.1 South America Ketorolac Tromethamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ketorolac Tromethamine Sales by Country (2021-2026)
  4. 10.1.3 South America Ketorolac Tromethamine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ketorolac Tromethamine Market Size by Country
  6. 10.2.1 South America Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ketorolac Tromethamine Market Size by Country (2021-2026)
  8. 10.2.3 South America Ketorolac Tromethamine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ketorolac Tromethamine Sales by Country
  2. 11.1.1 Middle East and Africa Ketorolac Tromethamine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ketorolac Tromethamine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ketorolac Tromethamine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ketorolac Tromethamine Market Size by Country
  6. 11.2.1 Middle East and Africa Ketorolac Tromethamine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ketorolac Tromethamine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ketorolac Tromethamine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ketorolac Tromethamine Value Chain Analysis
  2. 12.1.1 Ketorolac Tromethamine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ketorolac Tromethamine Production Mode & Process
  7. 12.2 Ketorolac Tromethamine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ketorolac Tromethamine Distributors
  10. 12.2.3 Ketorolac Tromethamine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst